Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 242

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Energy status dictates PD-L1 protein abundance and anti-tumor immunity to enable checkpoint blockade

Open access
Dai, Xiaoming, Bu, Xia, Gao, Yang, Guo, Jianping, Hu, Jia, Jiang, Cong, Zhang, Zhao, Xu, Kexin, Duan, Jinzhi, He, Shaohui, Zhang, Jinfang, Wan, Lixin, Liu, Tianjie, Zhou, Xiaobo, Hung, Mien-Chie, Freeman, Gordon J., Wei, Wenyi · 2021 · Molecular Cell

Abstract

SUMMARY Aberrant energy status contributes to multiple metabolic diseases, including obesity, diabetes and cancer, but the underlying mechanism remains elusive. Here, we report that ketogenic diet-induced changes in energy status enhance the efficacy of anti-CTLA-4 immunotherapy through decreasing PD-L1 protein levels and increasing expression of type I interferon and antigen presentation genes. Mechanistically, energy deprivation activates AMPK, which in turn phosphorylates PD-L1 on Ser283, thereby disrupting its interaction with CMTM4 and subsequently triggering PD-L1 degradation. In addition, AMPK phosphorylates EZH2, which disrupts PRC2 function, leading to enhanced IFNs and antigen presentation gene expression. Through these mechanisms, AMPK agonist or ketogenic diet enhances the efficacy of anti-CTLA-4 immunotherapy and improves the overall survival rate in syngeneic mouse tumor models. Our findings reveal a pivotal role for AMPK in regulating the immune response to immune-checkpoint blockade and advocate for combining ketogenic diet or AMPK agonist with anti-CTLA4 immunotherapy to combat cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.molcel.2021.03.037

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 242

Metadata

Authors
Dai, X., Bu, X., Gao, Y., Guo, J., Hu, J., Jiang, C., Zhang, Z., Xu, K., Duan, J., He, S., Zhang, J., Wan, L., Liu, T., Zhou, X., Hung, M.-C., Freeman, G. J., & Wei, W.
Venue
Molecular Cell
Publisher
Elsevier BV
Published
2021-06
Volume
81
Issue
11
Pages
2317-2331.e6
ISSN
1097-2765 (ISSN-L)
OpenAlex
W3158907042
Cited by
242
References
26
FWCI
13.29
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.